CH449641A - Verfahren zur Herstellung von neuen substituierten 6,7-Benzomorphanen - Google Patents

Verfahren zur Herstellung von neuen substituierten 6,7-Benzomorphanen

Info

Publication number
CH449641A
CH449641A CH1618967A CH1618967A CH449641A CH 449641 A CH449641 A CH 449641A CH 1618967 A CH1618967 A CH 1618967A CH 1618967 A CH1618967 A CH 1618967A CH 449641 A CH449641 A CH 449641A
Authority
CH
Switzerland
Prior art keywords
benzomorphans
preparation
new substituted
substituted
new
Prior art date
Application number
CH1618967A
Other languages
German (de)
English (en)
Inventor
B Block Fred
H Clarke Frank
Original Assignee
Geigy Ag J R
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Geigy Ag J R filed Critical Geigy Ag J R
Publication of CH449641A publication Critical patent/CH449641A/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/82Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22Bridged ring systems
    • C07D221/26Benzomorphans

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Discharge Lamp (AREA)
CH1618967A 1963-12-20 1964-11-30 Verfahren zur Herstellung von neuen substituierten 6,7-Benzomorphanen CH449641A (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33229663A 1963-12-20 1963-12-20

Publications (1)

Publication Number Publication Date
CH449641A true CH449641A (de) 1968-01-15

Family

ID=23297612

Family Applications (7)

Application Number Title Priority Date Filing Date
CH1618967A CH449641A (de) 1963-12-20 1964-11-30 Verfahren zur Herstellung von neuen substituierten 6,7-Benzomorphanen
CH1619167A CH449643A (de) 1963-12-20 1964-11-30 Verfahren zur Herstellung von neuen substituierten 6,7-Benzomorphanen
CH1619067A CH449642A (de) 1963-12-20 1964-11-30 Verfahren zur Herstellung von neuen substituierten 6,7-Benzomorphanen
CH1618767A CH449639A (de) 1963-12-20 1964-11-30 Verfahren zur Herstellung von neuen substituierten 6,7-Benzomorphanen
CH1538464A CH446371A (de) 1963-12-20 1964-11-30 Verfahren zur Herstellung von neuen substituierten 6,7-Benzomorphanen
CH1618867A CH449640A (de) 1963-12-20 1964-11-30 Verfahren zur Herstellung von neuen substituierten 6,7-Benzomorphanen
CH1538364A CH448118A (de) 1963-12-20 1964-11-30 Verfahren zur Herstellung von neuen substituierten 6,7-Benzomorphanen

Family Applications After (6)

Application Number Title Priority Date Filing Date
CH1619167A CH449643A (de) 1963-12-20 1964-11-30 Verfahren zur Herstellung von neuen substituierten 6,7-Benzomorphanen
CH1619067A CH449642A (de) 1963-12-20 1964-11-30 Verfahren zur Herstellung von neuen substituierten 6,7-Benzomorphanen
CH1618767A CH449639A (de) 1963-12-20 1964-11-30 Verfahren zur Herstellung von neuen substituierten 6,7-Benzomorphanen
CH1538464A CH446371A (de) 1963-12-20 1964-11-30 Verfahren zur Herstellung von neuen substituierten 6,7-Benzomorphanen
CH1618867A CH449640A (de) 1963-12-20 1964-11-30 Verfahren zur Herstellung von neuen substituierten 6,7-Benzomorphanen
CH1538364A CH448118A (de) 1963-12-20 1964-11-30 Verfahren zur Herstellung von neuen substituierten 6,7-Benzomorphanen

Country Status (12)

Country Link
AT (4) AT249277B (instruction)
BE (2) BE657406A (instruction)
CH (7) CH449641A (instruction)
DE (2) DE1445853A1 (instruction)
DK (4) DK108497C (instruction)
ES (4) ES307300A1 (instruction)
FR (2) FR4346M (instruction)
GB (2) GB1077711A (instruction)
IL (2) IL22642A (instruction)
NL (3) NL6414821A (instruction)
NO (2) NO119274B (instruction)
SE (2) SE322779B (instruction)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1506174B1 (en) 2002-05-17 2015-09-30 Taiwanj Pharmaceuticals Co., Ltd. Use of naltrexone for treating kidney and liver damage
US7501433B2 (en) 2002-05-17 2009-03-10 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
US7923454B2 (en) 2002-05-17 2011-04-12 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
US8017622B2 (en) 2003-05-16 2011-09-13 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
JP5486928B2 (ja) 2007-02-26 2014-05-07 ヴァイティー ファーマシューティカルズ,インコーポレイテッド 11β−ヒドロキシステロイドデヒドロゲナーゼ1のサイクリックウレアおよびカルバメートインヒビター
CA2697168A1 (en) 2007-07-26 2009-02-05 Vitae Pharmaceuticals, Inc. Synthesis of inhibitors of 11beta-hydroxysteroid dehydrogenase type 1
AR069207A1 (es) 2007-11-07 2010-01-06 Vitae Pharmaceuticals Inc Ureas ciclicas como inhibidores de la 11 beta - hidroxi-esteroide deshidrogenasa 1
TW200927115A (en) 2007-11-16 2009-07-01 Boehringer Ingelheim Int Aryl-and heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
EP2229368A1 (en) 2007-12-11 2010-09-22 Vitae Pharmaceuticals, Inc. Cyclic urea inhibitors of 11beta-hydroxysteroid dehydrogenase 1
TW200934490A (en) 2008-01-07 2009-08-16 Vitae Pharmaceuticals Inc Lactam inhibitors of 11 &abgr;-hydroxysteroid dehydrogenase 1
US8592409B2 (en) 2008-01-24 2013-11-26 Vitae Pharmaceuticals, Inc. Cyclic carbazate and semicarbazide inhibitors of 11β-hydroxysteroid dehydrogenase 1
JP5734666B2 (ja) 2008-02-11 2015-06-17 ヴァイティー ファーマシューティカルズ,インコーポレイテッド 11β−ヒドロキシステロイドデヒドロゲナーゼ1の1,3−オキサアゼパン−2−オン及び1,3−ジアゼパン−2−オン阻害剤
ATE531696T1 (de) * 2008-02-12 2011-11-15 Boehringer Ingelheim Int Harnstoff-derivate von benzomorphanen, entsprechende gerüste, medikamente mit solchen verbindungen und ihre verwendung
EP2254872A2 (en) 2008-02-15 2010-12-01 Vitae Pharmaceuticals, Inc. Cycloalkyl lactame derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
JP5696037B2 (ja) 2008-05-01 2015-04-08 ヴァイティー ファーマシューティカルズ,インコーポレイテッド 11β−ヒドロキシステロイドデヒドロゲナーゼ1の環状インヒビター
CN102089300B (zh) 2008-05-01 2014-06-18 生命医药公司 11β-羟基类固醇脱氢酶1的环状抑制剂
EP2291370B1 (en) 2008-05-01 2013-11-27 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
JP5451752B2 (ja) 2008-05-01 2014-03-26 ヴァイティー ファーマシューティカルズ,インコーポレイテッド 11β−ヒドロキシステロイドデヒドロゲナーゼ1の環状インヒビター
US8765780B2 (en) 2008-05-13 2014-07-01 Boehringer Ingelheim International Gmbh Alicyclic carboxylic acid derivatives of benzomorphans and related scaffolds, medicaments containing such compounds and their use
EP2324017B1 (en) 2008-07-25 2014-12-31 Boehringer Ingelheim International GmbH INHIBITORS OF 11beta-HYDROXYSTEROID DEHYDROGENASE 1
DK2324018T3 (da) 2008-07-25 2013-10-14 Boehringer Ingelheim Int Cykliske inhibitorer af 11 beta-hydroxysteroid dehydrogenase 1
AR073920A1 (es) 2008-10-23 2010-12-09 Boehringer Ingelheim Int Derivados urea de nortropanos sustituidos, medicamentos que contienen dichos compuestos , su uso en el tratamiento de enfermedades mediadas por la inhibicion de la enzima 11beta-hidroxiesteroide deshidrogenasa y proceso para su preparacion.
US8637505B2 (en) 2009-02-04 2014-01-28 Boehringer Ingelheim International Gmbh Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
US8680093B2 (en) 2009-04-30 2014-03-25 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
WO2010139673A1 (en) 2009-06-02 2010-12-09 Boehringer Ingelheim International Gmbh Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
JP5656986B2 (ja) 2009-06-11 2015-01-21 ヴァイティー ファーマシューティカルズ,インコーポレイテッド 1,3−オキサジナン−2−オン構造に基づく11β−ヒドロキシステロイドデヒドロゲナーゼ1の環状阻害剤
EP2448928B1 (en) 2009-07-01 2014-08-13 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
UY33001A (es) 2009-11-06 2011-05-31 Boehringer Ingelheim Int Derivados arilo y heteroarilcarbonilo de hexahidroindenopiridina y octahidrobenzoquinolina
EP2582698B1 (en) 2010-06-16 2016-09-14 Vitae Pharmaceuticals, Inc. Substituted 5-,6- and 7-membered heterocycles, medicaments containing such compounds, and their use
WO2011161128A1 (en) 2010-06-25 2011-12-29 Boehringer Ingelheim International Gmbh Azaspirohexanones as inhibitors of 11-beta-hsd1 for the treatment of metabolic disorders
EP2635268A1 (en) 2010-11-02 2013-09-11 Boehringer Ingelheim International GmbH Pharmaceutical combinations for the treatment of metabolic disorders
TWI537258B (zh) 2010-11-05 2016-06-11 百靈佳殷格翰國際股份有限公司 六氫茚并吡啶及八氫苯并喹啉之芳基-及雜環芳基羰基衍生物
JP2014524438A (ja) 2011-08-17 2014-09-22 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング インデノピリジン誘導体

Also Published As

Publication number Publication date
ES307301A1 (es) 1965-05-16
DK108495C (da) 1967-12-27
NL6414820A (instruction) 1965-06-21
CH448118A (de) 1967-12-15
DK108496C (da) 1967-12-27
AT249277B (de) 1966-09-12
DE1445854A1 (de) 1968-12-05
IL22642A (en) 1968-07-25
SE305657B (instruction) 1968-11-04
NO119274B (instruction) 1970-04-27
GB1077711A (en) 1967-08-02
GB1092394A (en) 1967-11-22
AT261126B (de) 1968-04-10
CH449643A (de) 1968-01-15
IL22643A (en) 1968-07-25
BE657406A (instruction) 1965-06-21
AT253687B (de) 1967-04-25
AT249276B (de) 1966-09-12
CH449639A (de) 1968-01-15
NO119273B (instruction) 1970-04-27
CH449640A (de) 1968-01-15
DK108497C (da) 1967-12-27
CH446371A (de) 1967-11-15
ES307302A1 (es) 1965-05-16
ES307300A1 (es) 1965-05-01
SE322779B (instruction) 1970-04-20
NL127995C (instruction)
FR4346M (instruction) 1966-08-16
FR4345M (instruction) 1966-08-16
ES307299A1 (es) 1965-05-16
DK106552C (da) 1967-02-20
BE657405A (instruction) 1965-06-21
DE1445853A1 (de) 1968-12-05
NL6414821A (instruction) 1965-06-21
CH449642A (de) 1968-01-15

Similar Documents

Publication Publication Date Title
CH449640A (de) Verfahren zur Herstellung von neuen substituierten 6,7-Benzomorphanen
CH469731A (de) Verfahren zur Herstellung von neuen 1,2,4-Oxadiazolen
CH448114A (de) Verfahren zur Herstellung von neuen 1,3,5-Triazinen
CH458587A (de) Verfahren zur Herstellung von 8,9,10,11-Tetrahydro-12-phthaloperinon
CH430722A (de) Verfahren zur Herstellung von neuen 5,6-Dihydro-dibenz(b,e)-azepinen
CH460766A (de) Verfahren zur Herstellung von 3,3-Alkyliden-19-nor-steroiden
CH479574A (de) Verfahren zur Herstellung von 13-Jod-14-oxo 13,14-seco-steroiden
AT244334B (de) Verfahren zur Herstellung von neuen 2, 1-Benzisothiazolen
AT251764B (de) Verfahren zur Herstellung von neuen 5-Joduracil-2'-desoxyribosid-3',5'-di-Estern
AT250372B (de) Verfahren zur Herstellung von neuen 4-Amino-5-hydroxypyridazonen-(6)
AT277984B (de) Verfahren zur Herstellung von neuen 4,4-Diphenylcyclohexylaminen
AT240356B (de) Verfahren zur Herstellung von neuen 1, 2-Diaryl-4-alkyl-3, 5-dioxo-pyrazolidinen
AT254852B (de) Verfahren zur Herstellung von neuen 1-Arylperchlor-2-azaalkenen-(2)
AT247848B (de) Verfahren zur Herstellung von 1, 3-Dioxo-2-alkylcyclopentanen
CH450450A (de) Verfahren zur Herstellung von neuen 1,4-Benzodioxanderivaten
CH439328A (de) Verfahren zur Herstellung von 3,5-Dijodthyroninen
CH441583A (de) Verfahren zur Herstellung von 1,4-Diarylamino-5-nitro-8-hydroxy-anthrachinonen
AT248445B (de) Verfahren zur Herstellung von neuen 1, 2-Dimehtylhexahydropyridazinen
AT253703B (de) Verfahren zur Herstellung von 3, 6-Dioxo-A-nor-B-homo-steroiden
CH471056A (de) Verfahren zur Herstellung von 2,5-Dialkoxybenzaldehyden
CH451151A (de) Verfahren zur Herstellung von 1,4-Benzoxazin-2-onen
CH464174A (de) Verfahren zur Herstellung von 2,6-Dichlor-4-nitrobenzamid
CH438316A (de) Verfahren zur Herstellung von substituierten 1,4-Benzoxazin-2-onen
AT246135B (de) Verfahren zur Herstellung von neuen 1,4-Benzodioxanderivaten
AT252205B (de) Verfahren zur Herstellung von 1,2-Di-aminomethylcyclobutan